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Abstract
Oscillating levels of adrenal glucocorticoid hormones are essential for optimal gene expression, and for maintaining
physiological and behavioural responsiveness to stress. The biological basis for these oscillations is not known, but a
neuronal ‘‘pulse generator’’ within the hypothalamus has remained a popular hypothesis. We demonstrate that pulsatile
hypothalamic activity is not required for generating ultradian glucocorticoid oscillations. We show that a constant level of
corticotrophin-releasing hormone (CRH) can activate a dynamic pituitary-adrenal peripheral network to produce ultradian
adrenocorticotrophic hormone and glucocorticoid oscillations with a physiological frequency. This oscillatory response to
CRH is dose dependent and becomes disrupted for higher levels of CRH. These data suggest that glucocorticoid oscillations
result from a sub-hypothalamic pituitary-adrenal system, which functions as a deterministic peripheral hormone oscillator
with a characteristic ultradian frequency. This constitutes a novel mechanism by which the level, rather than the pattern, of
CRH determines the dynamics of glucocorticoid hormone secretion.
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Introduction
A fundamental requisite for survival is the ability to respond
and adapt to a changing environment. This ability to respond to
change or ‘‘stress’’ becomes more complex in multicellular
organisms, and mammals have developed a well-integrated
organization of hormonal, neural, and immunological systems
that protect them from internal and external threats to their
homeostatic state [1–3]. One of the most important of these
systems, and one that is critical for life, is the hypothalamic-
pituitary-adrenal (HPA) axis. This neuroendocrine system regu-
lates the secretion of vital adrenal glucocorticoid hormones
(cortisol in humans and corticosterone in rodents), which have
major effects on brain and metabolic function and are essential
for successful recovery and adaptation to stress [4,5].
Central regulation of glucocorticoid secretion is predominantly
coordinated by the hypothalamic peptide corticotrophin-releasing
hormone (CRH) [6,7], the efficacy of which can be significantly
potentiated byotherhypothalamicfactors,mostnotablyvasopressin
[8]. CRH is synthesized by parvocellular neurons in the para-
ventricular nucleus (PVN) of the hypothalamus [9], and secreted
into the hypothalamic-pituitary portal circulation from axons
terminating in the external zone of the median eminence [10].
Activation of CRH receptors in corticotroph cells of the anterior
pituitary results in adrenocorticotrophic hormone (ACTH) secre-
tion into the general circulation, which in turn stimulates
glucocorticoid-secreting cells within the adrenal cortex (Figure 1A).
Circulating glucocorticoids regulate gene expression in cells
throughout the organism via activation of two widely expressed
transcription factors—the glucocorticoid receptor (GR) and miner-
alocorticoidreceptor(MR) [11]—aswell asactingdirectlyat the cell
membrane to initiate more rapid non-genomic signalling processes
[12–15]. Glucocorticoids also feed back on their own regulatory
system to inhibit HPA activity [16,17]. Inhibition occurs at the level
of the hippocampus and hypothalamus, and with particular
sensitivity at the level of the anterior pituitary (Figure 1A).
In common with other neuroendocrine systems that signal
through pituitary hormone secretion, the HPA axis is character-
ized by a dynamic ultradian rhythm, which is manifested by
oscillating levels of ACTH [18] and glucocorticoid hormones
(Figure 1B) both in the blood and in the brain [19]. At the cellular
level, glucocorticoid oscillations induce ‘‘gene pulsing’’ through
rapid, transient binding of glucocorticoid receptors to promoter
elements of glucocorticoid-responsive genes [20,21]. This dynamic
and versatile transcriptional system enables cells to rapidly detect
and respond to changes in circulating glucocorticoid levels and
provides a sensitive mechanism for the maintenance of homeo-
stasis [22]. Indeed, when the glucocorticoid rhythm is pharmaco-
logically replaced by constant levels of steroid, this results in
abnormal gene expression [21], and a desensitization of physio-
logical and behavioural responses to stress [23,24].
The origin of glucocorticoid oscillations is not known. Since
pulsatile patterns of CRH have been detected in cultured
hypothalamic explants, median eminence, and portal blood [25–
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adrenal system are a consequence of a neuronal ‘‘pulse generator’’
within the hypothalamus. However, there is a lack of concordance
between pulsatile patterns of hypothalamic factors and the
ultradian ACTH and glucocorticoid oscillation. In the rat, for
instance, CRH pulse frequency [26] is much higher (,3 pulses/h)
than the near-hourly oscillation in ACTH [18] and glucocorticoids
(Figure 1B). This suggests that episodic secretion of hypothalamic
hormones is not the primary controlling factor of the ultradian
rhythm and implies that oscillatory mechanisms exist at a sub-
hypothalamic level. This concept of a ‘‘peripheral oscillator’’ is in
keeping with in vivo lesion studies demonstrating maintenance of
ultradian pulsatility following hypothalamic-pituitary disconnec-
tion in the sheep [28], and a loss of circadian but not ultradian
glucocorticoid oscillation following suprachiasmatic nucleus lesions
in the rat (unpublished data).
Since glucocorticoids rapidly inhibit CRH-induced ACTH
secretion from the anterior pituitary [29–32], we postulated that
this fast inhibitory feedback process provides a potential mecha-
nism within the pituitary-adrenal system for generating oscillatory
dynamics. To explore this hypothesis further, and to determine
qualitatively the dynamics that result from hormonal interactions
between the anterior pituitary and adrenal cortex, we previously
developed a mathematical model based on differential equations
that incorporates rapid glucocorticoid inhibition of ACTH
secretion [33]. Numerical analysis of the model suggests that the
pituitary-adrenal system can support self-sustained ACTH and
glucocorticoid oscillations with a physiological ultradian frequen-
cy, even under conditions of constant CRH drive to the anterior
pituitary (Figure 1C–1D). In this model, the ACTH and
glucocorticoid oscillations have the same frequency, but they are
not synchronous—there is a small phase difference, with ACTH
oscillations preceding glucocorticoid oscillations (Figure 1D). The
model also predicts that the capacity for this oscillatory response
depends on the degree of hypothalamic drive, with higher levels of
CRH resulting in damped oscillations to steady-state (i.e.,
constant) levels of hormone (Figure 1E–1F).
Here we test these modelling predictions in vivo. Our data
show that a constant level of CRH can activate the pituitary-
adrenal system to produce ultradian hormone oscillations with a
physiological frequency, and that this oscillatory activity is
critically dependent on the level of hypothalamic drive, with
higher levels of CRH resulting in a loss of oscillation. These
results demonstrate that pulsatile secretion of hypothalamic CRH
is not required for ultradian oscillatory activity in the pituitary-
adrenal system, and support our theoretical hypothesis that rapid
glucocorticoid inhibition at the level of the anterior pituitary is
the primary factor regulating the ultradian dynamics of the
system.
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Figure 1. Regulation of glucocorticoid hormone secretion. (A)
Negative feedback in the HPA axis plays a key role in regulating
glucocorticoid (CORT) secretion. Neurons of the hypothalamic para-
ventricular nucleus (PVN) secrete CRH into the portal vein, which acts
on the anterior pituitary to release ACTH into the general circulation.
ACTH activates cells in the adrenal cortex to synthesize and secrete
CORT, which in turn feeds back directly on the anterior pituitary to
inhibit ACTH secretion, as well as acting at higher centres in the brain,
including the hypothalamus and hippocampus. (B) Endogenous
corticosterone (the main glucocorticoid in rodents) oscillations in a
freely behaving male Sprague-Dawley rat. Shaded region indicates the
dark phase. (C–F) Mathematical modelling predicts that ultradian ACTH
and glucocorticoid (CORT) oscillations are regulated by a systems-level
negative feedback mechanism in the pituitary-adrenal network,
independent of pulsatile hypothalamic activity. Numerical simulations
show that the pituitary-adrenal network can oscillate under conditions
of constant CRH drive to the pituitary (C–D). Oscillations in ACTH and
CORT are characterized by a small phase shift (shaded region indicates
phase difference between oscillation peaks). For higher levels of CRH
drive, the oscillations are rapidly damped to steady-state levels of
hormone (E–F). AU, arbitrary units.
doi:10.1371/journal.pbio.1001341.g001
Author Summary
Glucocorticoid steroid hormones, such as cortisol and
corticosterone, provide a rapid response to both physical
and psychological stress, and act on areas of the brain that
influence learning, memory, and behaviour. Glucocorti-
coids are released from the adrenal glands in near-hourly
pulses, which results in oscillating glucocorticoid levels in
the blood and in target organs. These hormone oscillations
can become disrupted during ageing and in stress-related
disease (e.g., major depression), so it is important to
identify the underlying mechanisms that govern their
dynamics. Although the origin of the oscillations is not
known, it is assumed that they are generated by a
neuronal ‘‘pulse generator’’ within the brain. In this study,
we present data that challenge this hypothesis. We
characterize a peripheral hormonal system and show that
constant levels of corticotrophin-releasing hormone can
induce and regulate hormone oscillations independent of
the brain. We also describe mechanisms that can disrupt
these oscillations. These findings have important implica-
tions for our understanding of glucocorticoid signalling in
both health and disease, and will be important for the
design of novel treatment strategies that take into account
timing of hormone administration to patients undergoing
steroid therapy for inflammatory or malignant disease.
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To test our hypothesis that the sub-hypothalamic pituitary-
adrenal system functions as an ultradian hormone oscillator, we
investigated the dynamics of glucocorticoid responses to different
levels of constant CRH stimulation in conscious freely behaving
male rats. Experiments were performed during the nadir of the
circadian cycle (0700–1300 h), when there is minimal endogenous
CRH [34,35], and no pulsatile secretion of corticosterone, the
main glucocorticoid in rodents (Figure 1B). Animals were infused
intravenously at a constant (i.e., non-pulsatile) rate for this 6-h
period with concentrations of CRH in the range 0–2.5 mg/h.
Circulating levels of corticosterone were measured in blood
samples collected prior to and throughout the infusion using an
automated blood-sampling system (see Materials and Methods).
To check that the animals were in a physiological basal state
throughout the procedure, we measured corticosterone levels in a
group of control animals infused with saline (Figure 2A–2B).
Corticosterone levels remained low throughout the duration of the
saline infusion and were not significantly different from cortico-
sterone levels measured during the same time period (0700–
1300 h) in a group of untreated animals (data not shown), as
assessed by analysis of the area under the curve (AUC, p.0.38).
In response to CRH infusion, corticosterone levels rose rapidly
(Figure 2C–2H) and the overall effect was dose dependent (AUC,
p,0.0001) (Figure 2I). There was a significant difference between
the groups treated with saline and 0.5 mg/h CRH (p,0.001), and
between the groups treated with 0.5 and 1.0 mg/h CRH
(p,0.001), but there was no significant difference between the
groups treated with 1.0 and 2.5 mg/h CRH (p.0.41). This
suggests that both of these higher levels of CRH result in maximal
pituitary-adrenal activation, which implies a systems-level ‘‘ceiling
effect’’ in the pituitary-adrenal network.
Computational modelling suggests that the dynamic activity of
the pituitary-adrenal system is fundamentally dependent on the
level of hypothalamic stimulation [33]. In agreement with this
prediction, constant infusion of CRH at different doses gave rise to
different temporal patterns of corticosterone secretion. In line with
the modelling hypothesis, constant infusion of CRH (0.5 mg/h)
induced ultradian corticosterone oscillations that persisted
throughout the infusion period (Figure 2C–2D). In contrast, and
also consistent with the qualitative predictions of the model, higher
doses of CRH (1.0 and 2.5 mg/h) caused a rapid activation of the
adrenals, but the oscillatory component of the response was
damped to constant, elevated levels of steroid (Figure 2E–2F,
CRH 1.0 mg/h; Figure 2G–2H, CRH 2.5 mg/h).
Although CRH is the predominant ACTH secretagogue in
humans and the rat [36], its ability to stimulate ACTH secretion
can be potentiated by other hypothalamic neuropeptides, most
notably vasopressin [8]. However, the consistency between
animals in the timing of the initial corticosterone response to
CRH, and the subsequent synchrony in oscillation throughout the
infusion (Figure 2J) indicates that the corticosterone response is not
dependent on the release of any other endogenous hypothalamic
factors, including vasopressin. This is in keeping with previous
observations that blocking vasopressin actions on the anterior
pituitary (using a vasopressin V1b receptor antagonist) has no
effect on endogenous corticosterone oscillations during the
circadian peak [37], suggesting that vasopressin is not a significant
factor in regulating the ultradian dynamics of the system.
If the mechanism regulating endogenous corticosterone oscilla-
tions during the circadian peak is the same mechanism that is
activated by the constant infusion of exogenous CRH, there
should be good agreement between the characteristic frequencies
of endogenous and CRH-induced oscillations. To test this, we
computed the dominant frequency component in the CRH-
induced oscillations, and compared this with the dominant
frequency component in endogenous corticosterone oscillations
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Figure 2. Glucocorticoid response to constant CRH infusion. (A–
H) Individual (A, C, E, G) and mean (B, D, F, H) corticosterone responses
to constant saline (A–B) or CRH infusion (0.5 mg/h, C–D; 1.0 mg/h, E–F;
2.5 mg/h, G–H). Grey bar indicates the period of infusion; error bars
represent mean 6 standard error of the mean (SEM) (n=6–8 per
group). (I) Dose-dependent effect of CRH on the corticosterone
response. Overall effect of the CRH infusion was significant (AUC,
p,0.0001; Kruskal-Wallis ANOVA on ranks). Error bars represent mean 6
SEM (n=6–8 per group); *p,0.001. (J) Synchronous corticosterone
oscillations (in individual rats) in response to constant CRH infusion
(0.5 mg/h; n=6). Grey bar indicates the period of infusion.
doi:10.1371/journal.pbio.1001341.g002
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CRH-induced oscillations, there was a peak frequency of ,1
pulse/h for all animals (Figure 3A–3B; mean peak frequen-
cy=0.89 pulses/h; peak frequency range=0.79–0.93 pulses/h).
We then measured corticosterone levels in untreated control rats
during the circadian peak, when endogenous CRH is maximal
[34,35] and corticosterone is pulsatile (Figure 1B). Corticosterone
oscillations were observed in all animals (Figure 3C), and
frequency analysis of the data (Figure 3D) revealed no significant
difference between these endogenous oscillations and the oscilla-
tions induced by constant CRH infusion (p.0.57) (Figure 3E).
The consistency in oscillation frequency between different
animals infused with constant CRH suggests that the oscillations
are regulated by a generic mechanism at a sub-hypothalamic level.
Furthermore, the maintenance of this dominant frequency
component throughout the period of CRH infusion (Figure 3F)
suggests that the underlying oscillator is deterministic—as opposed
to stochastic—in agreement with our modelling hypothesis [33].
Numerical simulations of the model indicate that glucocorticoid
oscillations induced by constant CRH stimulation are driven by
oscillations in ACTH (Figure 1C–1D). Ultradian ACTH oscilla-
tions have been observed in the rat [18], and have been shown to
be a critical factor in regulating pulsatile glucocorticoid secretion
from the adrenal cortex [38]. Moreover, coordinated ACTH and
glucocorticoid oscillations have been observed in man [39]. To
confirm that the constant CRH infusion generates oscillations in
both hormones, we infused CRH (0.5 mg/h) from 0700–0940 h
and measured circulating levels of both ACTH and corticosterone
in samples collected at 20-min intervals throughout the infusion
(see Materials and Methods). In agreement with the modelling
predictions, CRH induced ACTH and corticosterone oscillations
that persisted throughout the infusion period (Figure 4A–4B).
A key feature of the oscillation predicted by numerical
simulations is a small phase shift between the two hormones—
ACTH oscillations preceding glucocorticoid oscillations
(Figure 1C–1D). This small phase shift could not be detected in
the CRH-induced ACTH and corticosterone oscillations
(Figure 4A–4B) because of the sampling frequency (20-min inter-
sample interval). Therefore, we measured both ACTH and
corticosterone at a higher sampling frequency (5-min inter-sample
interval) over the first 25 min of the CRH infusion (0.5 mg/h),
covering the initial activation phase of the first pulse. Both
hormones rose rapidly in response to CRH (ACTH, p,0.0001;
corticosterone, p,0.005), with the ACTH increase preceding a
delayed rise in corticosterone (Figure 4C–4D). Specifically, ACTH
was significantly different from basal (time zero) by 10 min
(p,0.005), whereas corticosterone was not significantly different
from basal (time zero) until 20 min (p,0.05). This phase shift
between ACTH and corticosterone presumably reflects the time
taken for de novo biosynthesis and release of corticosterone from
the adrenal cortex [40].
We then checked that this phase relationship is maintained over
the full pituitary-adrenal oscillation. Since collection of large
volumes of plasma (required for sensitive ACTH assay) can
activate a stress response [41], this precludes high-frequency blood
sampling (for ACTH measurement) for prolonged periods in the
rat. We therefore used an alternative experimental approach in
which animals were killed by decapitation at 10-min intervals
throughout the first 70 min of the CRH infusion (0.5 mg/h);
ACTH and corticosterone levels were measured in plasma
obtained from trunk blood (see Materials and Methods). As
observed in the case of high-frequency sampling (Figure 4C–4D),
the CRH-induced increase in corticosterone was delayed relative
to the increase in ACTH, and this phase shift was maintained over
the duration of the pulse (Figure 4E).
These results challenge the long-standing view that glucocorti-
coid oscillations are a consequence of pulsatile CRH secretion
from a neuronal ‘‘pulse generator’’ within the hypothalamus
[26,27]. Our approach was based on the premise that feedback is a
key regulatory feature of biological oscillators [42], and on our
numerical results [33], suggesting that a systems-level dynamic
balance between positive feedforward and negative feedback—
CRH stimulation against rapid glucocorticoid inhibition of ACTH
secretion—provides a mechanism for generating ultradian oscil-
lations in ACTH and glucocorticoid hormone secretion. Testing
this modelling prediction in vivo, our results show that constant
CRH stimulation of the anterior pituitary is sufficient to generate
ACTH and glucocorticoid oscillations at a physiological ultradian
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Figure 3. Frequency comparison of CRH-induced and endog-
enous glucocorticoid oscillations. (A) Individual corticosterone
oscillations in response to constant CRH infusion (0.5 mg/h). Grey bar
indicates the period of infusion. (B) Normalized power spectra of the
corticosterone oscillations in (A). (C) Corticosterone oscillations during
the circadian peak in untreated control (UC) rats. Shaded region
indicates the dark phase. (D) Normalized power spectra of the
corticosterone oscillations in (C). (E) Mean peak frequency (i.e.,
frequency corresponding to the maximum power in the spectrum) of
corticosterone oscillations in response to constant CRH infusion (0.5 mg/
h; CRH; n=6), and of corticosterone oscillations during the circadian
peak in untreated control rats (UC; n=13). Error bars represent mean 6
standard error of the mean (SEM). (F) Frequency evolution of the
corticosterone oscillations in (A). AU, arbitrary units.
doi:10.1371/journal.pbio.1001341.g003
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outside the central nervous system.
The hormone oscillations generated by this system are not
simply a dynamic epiphenomenon of the pituitary-adrenal
interaction, but have significant biological impact. Glucocorticoid
oscillations are essential for optimal transcriptional regulation
[20,21], and are also likely to be important for more rapid non-
transcriptional mechanisms of steroid action in the brain [43] that
can alter behavioural function within minutes [44,45]. Exposure of
tissues to abnormal glucocorticoid levels due to prolonged stress
[46] and raised CRH [47,48], or due to the loss of ultradian
pulsatility that has been detected in ageing animals [49], will
modify glucocorticoid signalling, and could be an important factor
for both stress- and age-related disease.
Materials and Methods
Subjects
All experiments were conducted on adult male Sprague-Dawley
rats (Harlan Laboratories, Inc.) weighing ,250 g at the time of
surgery. Animals were housed in groups of four per cage and were
given at least 1 wk to acclimatize to the housing facility prior to
surgery. Rats were maintained under standard environmental
conditions (2161uC) under a 14-h light, 10-h dark schedule (lights
on at 0500 h). Food and water were freely available throughout
the experiments. All animal procedures were conducted in
accordance with Home Office guidelines and the UK Animals
(Scientific Procedures) Act, 1986.
Surgical Procedures
Animals were anaesthetized with a combination of Hypnorm
(0.32 mg/kg fentanyl citrate and 10 mg/kg fluanisone, IM;
Janssen Pharmaceuticals) and diazepam (2.6 mg/kg, IP; Phoenix
Pharmaceuticals). Two silastic-tipped (Merck) polythene cannulae
(Portex) were pre-filled with pyrogen-free heparinized (10 IU/ml)
isotonic saline. The right jugular vein was exposed and both
cannulae inserted into the vessel until they lay close to the entrance
to the right atrium. This permits simultaneous intravenous blood
sampling (via the sampling cannula) and substance infusion (via
the infusion cannula). The free ends of the cannulae were
exteriorized through a scalp incision and tunnelled through a
protective spring that was anchored to the parietal bones using two
stainless steel screws and self-curing dental acrylic. Following
recovery, animals were individually housed in a room containing
an automated blood-sampling system. The end of the protective
spring was attached to a two-channel swivel (Instech Laboratories,
Inc.), which rotates through 360u in the horizontal plane and 180u
in the vertical plane, providing the animals with maximal freedom
of movement. Animals were given a 5-d recovery period prior to
experiments. Throughout this time, both cannulae were flushed
daily with heparinized saline to maintain patency.
Drug Infusions
Rats received a constant intravenous infusion of either 0.9%
saline solution (vehicle control animals) or synthetic human/rat
CRH (University of Bristol Peptide Synthesis Service) dissolved in
0.9% saline solution. In all experiments, drugs were infused
through the infusion cannula at a volume infusion rate of 0.5 ml/h
using an automated infusion pump (PHD ULTRA syringe pump;
Harvard Apparatus, Ltd.).
Experimental Design
In the experiments measuring basal corticosterone levels over
24 h, corticosterone levels in response to saline or CRH infusion,
or basal corticosterone oscillations during the circadian peak,
blood samples were collected from the sampling cannula using an
automated blood-sampling system [50]. In the experiment
measuring basal corticosterone levels over 24 h (Figure 1B), blood
samples were collected every 10 min from 1400–1350 h. In the
experiments measuring corticosterone levels in response to saline
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(0.5 mg/h) over the duration of the first pulse (n=3–7 per time point).
Grey bar indicates the period of infusion (starting at 0700 h); error bars
represent mean 6 standard error of the mean (SEM).
doi:10.1371/journal.pbio.1001341.g004
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constantly infused with saline or CRH (0.5–2.5 mg/h) from
0700–1300 h; blood samples were collected every 5 min from
0600–1300 h. In the experiments measuring basal corticosterone
oscillations during the circadian peak (Figure 3C), blood samples
were collected every 5 min from 1530–2100 h. At the end of each
experiment, the plasma fraction was separated by centrifugation
(15 min, 3,120 g,4 uC) and stored at 220uC until processed for
corticosterone measurement.
In the experiments measuring ACTH and corticosterone
oscillations in response to CRH infusion (Figure 4A–4B), rats
received a constant CRH infusion (0.5 mg/h) from 0700–0940 h
and blood samples were collected manually from the sampling
cannula every 20 min throughout the infusion. In the experiments
measuring ACTH and corticosterone levels in response to CRH
during the initial activation phase (Figure 4C–4D), rats received a
constant CRH infusion (0.5 mg/h) from 0700–0725 h and blood
samples were collected manually from the sampling cannula every
5 min throughout the infusion. Blood samples from both
experiments were immediately mixed with EDTA (10 ml, 0.5 M,
pH 7.4) and placed on crushed ice. The plasma fraction was
separated by centrifugation (15 min, 3,120 g,4 uC) within 20 min
of sample collection and stored at 220uC until processed for
ACTH and corticosterone measurement.
In the experiment measuring ACTH and corticosterone levels
in response to CRH infusion over the first pulse (Figure 4E), rats
received a constant CRH infusion (0.5 mg/h) from 0700–0810 h.
At 10-min intervals throughout the CRH infusion, rats were killed
by decapitation following an overdose of 0.3 ml sodium pento-
barbital (Euthatal, 200 mg/ml; Merial). Trunk blood was collected
and immediately mixed with EDTA (50 ml, 0.5 M, pH 7.4) and
placed on crushed ice. The plasma fraction was separated by
centrifugation (15 min, 3,120 g,4 uC) within 20 min of sample
collection and stored at 220uC until processed for ACTH and
corticosterone measurement.
Corticosterone RIA
Corticosterone was measured in plasma by radioimmunoassay
(RIA) [51]. Samples were diluted in a citrate buffer (pH 3.0) to
denature the binding globulin. Antisera was supplied by G Makara
(Institute of Experimental Medicine, Budapest, Hungary), and
[125I] corticosterone was purchased from Izotop (Institute of
Isotopes Co. Ltd., Budapest, Hungary). The intra- and inter-assay
coefficients of variation of the corticosterone RIA were 14.1% and
15.3%, respectively.
ACTH IRMA
ACTH was measured in plasma by immunoradiometric assay
(IRMA; DiaSorin Ltd.), in accordance with the manufacturer’s
protocol. The intra- and inter-assay coefficients of variation of the
ACTH IRMA were 2.8% and 6.4%, respectively.
Data Analysis
Overall corticosterone responses to saline or CRH infusion were
assessed by AUC. Characterization of oscillatory corticosterone
responses induced by CRH infusion, and of endogenous
corticosterone oscillations recorded during the circadian peak,
was performed using spectral methods. Missing data points were
linearly interpolated and data were detrended using the Smooth-
ness Priors Approach (SPA) [52] with the smoothing parameter set
at l=30. This parameter value was chosen so as to remove long
term changes in the mean (i.e., low-frequency fluctuations), while
keeping the higher-frequency ultradian fluctuations that were the
focus in this study. To define the frequency of the oscillatory
corticosterone data, we computed the power spectrum of the
detrended data using the Discrete Fourier Transform (DFT)
applied to a time window corresponding to the period of CRH
infusion (0700–1300 h), or to the period of sampling (1530–
2100 h) for the basal corticosterone oscillations recorded during
the circadian peak. The peak frequency was then taken as the
frequency value corresponding to the maximum spectral power of
the DFT, which was calculated using a quadratic interpolation.
Spectrograms were computed using the Short-Time Fourier
Transform (STFT).
Statistical Analysis
Statistical significance level was set at p,0.05. Saline-infused
corticosterone responses and untreated corticosterone profiles
were compared using the non-parametric Mann-Whitney U test.
The overall effect of CRH treatment on AUC was assessed using
the non-parametric Kruskal-Wallis ANOVA on ranks test, and
post hoc multiple comparisons were performed using the Mann-
Whitney U Test with the statistical significance level adjusted using
the Bonferroni correction. Peak frequencies obtained using the
DFT, for the groups with CRH-induced corticosterone oscillations
and endogenous corticosterone oscillations during the circadian
peak, were compared using the Mann-Whitney U test. The
ACTH and corticosterone response to constant CRH infusion was
analyzed using one-way ANOVA, followed by Fisher Least
Significant Difference (LSD) post hoc test.
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